Antag Therapeutics Competitors and Similar CompaniesClear all
Antag Therapeutics's competitors and similar companies include Zealand Pharma, MannKind Corporation, Hua Medicine and Zucara Therapeutics.
 Antag Therapeutics Antag Therapeutics is a preclinical-stage biotechnology company focused on developing therapies for dietary-related metabolic diseases. |  Zealand Pharma Zealand Pharma is a biotechnology company that discovers, designs, and develops peptide-based medicines. |  MannKind Corporation MannKind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for patients. |  Zucara Therapeutics Zucara Therapeutics is a company developing drug therapies to prevent hypoglycemia in people with diabetes. | ||
Founding Date | Founding Date 2017 | Founding Date 1998 | Founding Date 1991 | Founding Date 2011 | Founding Date 2015 |
Type | Type Subsidiary | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations København, DK HQ | Locations Søborg, DK HQ Boston, US Marlborough, US | Locations Westlake Village, US HQ Danbury, US | Locations Shanghai, CN HQ Beijing, CN Wuhan, CN Hong Kong, HK | Locations Toronto, CA HQ |
Employees | Employees 20 | Employees 385 | Employees 39513% increase | Employees 168 | Employees 11 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 8.4 b | Valuation ($) 1.9 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) kr9.2b (FY, 2025) | Revenue (est.) $349m (FY, 2025) | Revenue (est.) ¥492.9m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods kr816k (FY, 2025) | Cost of goods $26.8m (FY, 2025) | Cost of goods ¥180.1m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit (kr13.1m) (FY, 2021) | Gross profit kr9.3b (FY, 2025) | Gross profit $322.2m (FY, 2025) | Gross profit ¥1.6b (FY, 2025) | Gross profit N/A |
Net income | Net income (kr14.9m) (FY, 2021) | Net income kr6.5b (FY, 2025) | Net income $5.9m (FY, 2025) | Net income ¥1.1b (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 200m | Total funding raised $ 242.4m | Total funding raised $ 24.9m |
For sources of this data, please see the company profile
View Company Profiles
Zealand Pharma
HQ
Søborg, DK
Employees
385
Zealand Pharma is a biotechnology company that discovers, designs, and develops peptide-based medicines.
View companyMannKind Corporation
HQ
Westlake Village, US
Employees
395↑ 13% increase
MannKind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for patients.
View company
Hua Medicine
HQ
Shanghai, CN
Employees
168
Hua Medicine (华领医药) is a drug development company.
View companyZucara Therapeutics
HQ
Toronto, CA
Employees
11
Zucara Therapeutics is a company developing drug therapies to prevent hypoglycemia in people with diabetes.
View company